Posted by Michael Wonder on 19 Nov 2024
Zilucoplan sodium for the treatment of patients with antibody positive generalised myasthenia gravis (revised draft guidance)
14 November 2024 - NICE has produced updated guidance on the use of zilucoplan sodium in the NHS in England.
For the time being, zilucoplan sodium is not still not recommended for use as an add-on to standard treatment for adults with generalised myasthenia gravis who test positive for anti-acetylcholine receptor antibodies.
